[ad_1]
“Are Italy’s shares at risk? Not at the moment, I don’t think so ”. So Piero Di Lorenzo, CEO and President of Irbm di Pomezia, which together with AstraZeneca and at the University of Oxford developed the vaccine, ruled out problems in the distribution of serum. However, there is no shortage of “but” that Di Lorenzo wanted to underline and explain during an interview with The newspaper: “When will the green light come? It all depends on Ema. We have done our part. In October we delivered all the documentation and then AstraZeneca released the documents to clarify the issue of the half dose less. We can’t do more but wait”.
Di Lorenzo has not been able to give certain times on the ok, which could arrive in mid-January, but he assured us that “we will be ready, or rather, very ready, to distribute.” Finally, the CEO of Irbm also expressed his opinion on the excess of advertisements, not always true, of the pharmaceutical companies that have somewhat disoriented ordinary people: “I find the controversy over company advertisements tiring. It was okay to do them, alas otherwise. It was necessary to inform people affected by the pandemic. That is why maximum transparency is good, otherwise we would have played the role of the priest who speaks in Latin so as not to be understood ”.
[ad_2]
